Cargando…
Corrigendum: Interferon-α2b Treatment for COVID-19
Autores principales: | Zhou, Qiong, Chen, Virginia, Shannon, Casey P., Wei, Xiao-Shan, Xiang, Xuan, Wang, Xu, Wang, Zi-Hao, Tebbutt, Scott J., Kollmann, Tobias R., Fish, Eleanor N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653513/ https://www.ncbi.nlm.nih.gov/pubmed/33193462 http://dx.doi.org/10.3389/fimmu.2020.615275 |
Ejemplares similares
-
Interferon-α2b Treatment for COVID-19
por: Zhou, Qiong, et al.
Publicado: (2020) -
Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities
por: Zhou, Qiong, et al.
Publicado: (2020) -
Omicron variants of SARS-CoV-2 and long COVID
por: Yang, Chengliang, et al.
Publicado: (2022) -
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
por: Mazewski, Candice, et al.
Publicado: (2020) -
Corrigendum: Type I Interferon Regulates the Survival and Functionality of B Cells in Rainbow Trout
por: Benedicenti, Ottavia, et al.
Publicado: (2021)